Sumatriptan Injection
Product Images NDC 36000-289

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 36000-289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-label (Image 01)

This is a description of a medication with NDC code 36000-289-01 indicated for subcutaneous injection only. Each vial contains 0.5 mL of solution which has 8.4 mg of sumatriptan succinate equivalent to 6 mg of sumatriptan and 3.5 mg of sodium chloride. The solution is for injection and is made in India by LM. The medication is a single-dose vial manufactured for Baxter Healthcare Corporation with an expiration date of 2021-10-06.*

FDA Label Image

Carton-label-01 (Image 02)

FDA Label Image

Carton-label-02 (Image 03)

FDA Label Image

Carton-label-03 (Image 04)

FDA Label Image

Structural Formula (Sum05 0000 01)

FDA Label Image

Figure 1 (Sum05 0000 02)

The given text appears to be a part of a research report that presents the estimated percentage of patients with relief after taking Sumatriptan and Placebo. However, the description does not provide much context to infer what kind of relief the patients experienced. The numbers 100, 127, 131, and 20-25 probably refer to the sample size and time interval of the experiment.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.